Bethyl Laboratories
Human IL-1 beta ELISA KitNew
ELISA Kits
Catalog #E82-002
TargetHuman IL-1 beta
ReactivityHuman
ApplicationELISA
Image 1 of 1
local_shipping
Order within 17 hours and 45 minutes for shipment by Tuesday, November 24
Product Description
IL1B is a member of the interleukin 1 cytokine family. This cytokine is produced by activated macrophages as a proprotein, which is proteolytically processed to its active form by caspase 1 (CASP1/ICE). This cytokine is an important mediator of the inflammatory response, and is involved in a variety of cellular activities, including cell proliferation, differentiation, and apoptosis. The induction of cyclooxygenase-2 (PTGS2/COX2) by this cytokine in the central nervous system (CNS) is found to contribute to inflammatory pain hypersensitivity. This gene and eight other interleukin 1 family genes form a cytokine gene cluster on chromosome 2.
Specifications
Reactivity
Human
Target Identity
TargetHuman IL-1 beta
Gene ID3553
Gene Symbol
IL1B
Gene Name
interleukin 1 beta
Uniprot IDP01584
Product Information
Applications
ELISA
Assay Type
Sandwich ELISA
Assay Range
0.41 pg/ml - 100 pg/ml
Sample Type
Serum, Plasma, & Cell Culture Supernatant
Detection Method
Biotinylated-Streptavidin-HRP
Storage Conditions
2 - 8 °C
Shelf Life
6 months from date of receipt
Contents
- Human IL-1 beta Pre-Coated 96-well Strip Plate, 1 each
- Human IL-1 beta Standard vial, 2 each
- Human IL-1 beta Detection Antibody
- Assay Diluent(s)
- Streptavidin-HRP Solution, 200µl
- TMB Substrate, 12 ml
- Stop Solution, 12 ml
- 20X Wash Buffer, 25 ml
- Sealing Tape, 2 sheets
Country of Origin
USA
Documents
Safety Data SheetPDF · E82-002Open
Product DatasheetPDF · E82-002 · Lot 250811 (current lot)Open
Services
Antibody Conjugation
Antibody and conjugate formats developed together, built to your specification.
Request CustomizationCustom Monoclonal Antibody Discovery Services
Full custom monoclonal development, from immunization through validation.
Explore Monoclonal DevelopmentVHH Discovery
Single-domain antibodies for structurally difficult targets a conventional monoclonal can't reach.
Explore VHH DiscoveryResources
1



